Show simple item record

Neutralising antibody potency against SARS-CoV-2 wild- type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

dc.contributor.authorLiu, Z
dc.contributor.authorLe, K
dc.contributor.authorZhou, X
dc.contributor.authorAlexander, JL
dc.contributor.authorLin, S
dc.contributor.authorBewshea, C
dc.contributor.authorChanchlani, N
dc.contributor.authorNice, R
dc.contributor.authorMcDonald, TJ
dc.contributor.authorLamb, CA
dc.contributor.authorSebastian, S
dc.contributor.authorKok, K
dc.contributor.authorLees, CW
dc.contributor.authorHart, AL
dc.contributor.authorPollok, RC
dc.contributor.authorBoyton, RJ
dc.contributor.authorAltmann, DM
dc.contributor.authorPollock, KM
dc.contributor.authorGoodhand, JR
dc.contributor.authorKennedy, NA
dc.contributor.authorAhmad, T
dc.contributor.authorPowell, N
dc.contributor.authorCLARITY Study Investigators, CLARITYSI
dc.date.accessioned2023-09-05T15:48:41Z
dc.date.available2022-11-09
dc.date.available2023-09-05T15:48:41Z
dc.date.issued2023
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/90470
dc.format.extent145 - 156
dc.relation.ispartofLANCET GASTROENTEROLOGY & HEPATOLOGY
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleNeutralising antibody potency against SARS-CoV-2 wild- type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort studyen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/S2468-1253(22)00389-2
pubs.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:001030527800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue2en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume8en_US
qmul.funderThe Durability of immune Responses to vaccination against SARS-CoV-2 and its Variants.::Medical Research Councilen_US
qmul.funderThe Durability of immune Responses to vaccination against SARS-CoV-2 and its Variants.::Medical Research Councilen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States